BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 14726627)

  • 1. Oxidative stress - a link between endothelial injury, coagulation activation, and atherosclerosis in haemodialysis patients.
    Pawlak K; Naumnik B; Brzósko S; Pawlak D; Myśliwiec M
    Am J Nephrol; 2004; 24(1):154-61. PubMed ID: 14726627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term erythropoietin therapy does not affect endothelial markers, coagulation activation and oxidative stress in haemodialyzed patients.
    Pawlak K; Pawlak D; Mysliwiec M
    Thromb Res; 2007; 120(6):797-803. PubMed ID: 17391740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extrinsic coagulation pathway activation and metalloproteinase-2/TIMPs system are related to oxidative stress and atherosclerosis in hemodialysis patients.
    Pawlak K; Pawlak D; Mysliwiec M
    Thromb Haemost; 2004 Sep; 92(3):646-53. PubMed ID: 15351863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated resistin is related to inflammation and residual renal function in haemodialysed patients.
    Malyszko J; Malyszko JS; Kozminski P; Pawlak K; Mysliwiec M
    Nephrology (Carlton); 2007 Jun; 12(3):246-53. PubMed ID: 17498119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Method of dialysis therapy and selected markers of oxidative stress and endothelial injury in patients with chronic renal failure].
    Pawlak K; Pawlak D; Myśliwiec M
    Pol Arch Med Wewn; 2005 Jan; 113(1):21-6. PubMed ID: 16130597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating beta-chemokines and matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 system in hemodialyzed patients--role of oxidative stress.
    Pawlak K; Pawlak D; Mysliwiec M
    Cytokine; 2005 Jul; 31(1):18-24. PubMed ID: 15896974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atherosclerosis is associated with plasminogen activator inhibitor type-1 in chronic haemodialysis patients.
    Peng Y; Liu H; Liu F; Ouyang L; Cheng M; Gao L; Pan F; Liu Y; Chen X; Li J
    Nephrology (Carlton); 2008 Oct; 13(7):579-86. PubMed ID: 19161364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kynurenines and oxidative status are independently associated with thrombomodulin and von Willebrand factor levels in patients with end-stage renal disease.
    Pawlak K; Domaniewski T; Mysliwiec M; Pawlak D
    Thromb Res; 2009 Sep; 124(4):452-7. PubMed ID: 19477487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired flow-mediated vasodilation, carotid artery intima-media thickening, and elevated endothelial plasma markers in obese children: the impact of cardiovascular risk factors.
    Meyer AA; Kundt G; Steiner M; Schuff-Werner P; Kienast W
    Pediatrics; 2006 May; 117(5):1560-7. PubMed ID: 16651309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accelerated atherosclerosis in haemodialysis patients; correlation of endothelial function with oxidative DNA damage.
    Kaya Y; Ari E; Demir H; Soylemez N; Cebi A; Alp H; Bakan E; Gecit I; Asicioglu E; Beytur A
    Nephrol Dial Transplant; 2012 Mar; 27(3):1164-9. PubMed ID: 21821836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient characteristics rather than the type of dialyser predict the variability of endothelial derived surface molecules in chronic haemodialysis patients.
    Grooteman MP; Gritters M; Wauters IM; Schalkwijk CG; Stam F; Twisk J; Ter Wee PM; Nubé MJ
    Nephrol Dial Transplant; 2005 Dec; 20(12):2751-8. PubMed ID: 16188898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visfatin and endothelial function in dialyzed patients.
    Malyszko J; Malyszko JS; Mysliwiec M
    Nephrology (Carlton); 2010 Mar; 15(2):190-6. PubMed ID: 20470278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic viral hepatitis C, oxidative stress and the coagulation/fibrinolysis system in haemodialysis patients.
    Pawlak K; Zolbach K; Borawski J; Mysliwiec M; Kovalchuk O; Chyczewski L; Pawlak D
    Thromb Res; 2008; 123(1):166-70. PubMed ID: 18452978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired renal function and duration of dialysis therapy are associated with oxidative stress and proatherogenic cytokine levels in patients with end-stage renal disease.
    Pawlak K; Pawlak D; Mysliwiec M
    Clin Biochem; 2007 Jan; 40(1-2):81-5. PubMed ID: 17046733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue factor and urokinase-type plasminogen activator system are related to the presence of cardiovascular disease in hemodialysis patients.
    Pawlak K; Pawlak D; Mysliwiec M
    Thromb Res; 2007; 120(6):871-6. PubMed ID: 17331567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial cell activation in cutaneous vasculitis.
    Jurd KM; Stephens CJ; Black MM; Hunt BJ
    Clin Exp Dermatol; 1996 Jan; 21(1):28-32. PubMed ID: 8689765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inter-relationships of indices of endothelial damage/dysfunction [circulating endothelial cells, von Willebrand factor and flow-mediated dilatation] to tissue factor and interleukin-6 in acute coronary syndromes.
    Lee KW; Blann AD; Lip GY
    Int J Cardiol; 2006 Aug; 111(2):302-8. PubMed ID: 16324758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural changes in carotid arteries and impairment of fibrinolysis in hemodialyzed and peritoneally dialyzed patients.
    Małyszko J; Łebkowska U; Małyszko JS; Myśliwiec M
    Med Sci Monit; 2009 Dec; 15(12):CR644-9. PubMed ID: 19946236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidative stress effects fibrinolytic system in dialysis uraemic patients.
    Pawlak K; Pawlak D; Mysliwiec M
    Thromb Res; 2006; 117(5):517-22. PubMed ID: 15964061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular disease on hemodialysis: predictors of atherosclerosis and survival.
    Balsam A; El Kossi MM; Lord R; El Nahas AM
    Hemodial Int; 2009 Jul; 13(3):278-85. PubMed ID: 19614783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.